Variant report

Variant	nsv1032971
Chromosome Location	chr5:17462317-17515789
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:211)
CpG islands
(count:492)
Chromatin interactive
region (count:7)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:211 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr5:17492224-17492379	K562	blood:	n/a	n/a
2	BATF	chr5:17499625-17499833	GM12878	blood:	n/a	n/a
3	BCL11A	chr5:17499619-17499851	GM12878	blood:	n/a	n/a
4	BCL11A	chr5:17499603-17499787	GM12878	blood:	n/a	n/a
5	CEBPB	chr5:17479634-17479713	H1-hESC	embryonic stem cell:	n/a	chr5:17479700-17479711
6	CEBPB	chr5:17504178-17504267	HepG2	liver:	n/a	n/a
7	CEBPB	chr5:17479590-17479792	HepG2	liver:	n/a	chr5:17479700-17479711
8	CEBPB	chr5:17486902-17487265	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr5:17483315-17483373	Hela-S3	cervix:	n/a	n/a
10	CTCF	chr5:17468380-17468530	GM12865	blood:	n/a	n/a
11	CTCF	chr5:17468405-17468580	GM19239	blood:	n/a	n/a
12	CTCF	chr5:17468460-17468610	MCF-7	breast:	n/a	n/a
13	CTCF	chr5:17491692-17491836	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr5:17468482-17468518	GM12891	blood:	n/a	n/a
15	CTCF	chr5:17507228-17507340	GM13976	blood:	n/a	n/a
16	CTCF	chr5:17468470-17468546	MCF-7	breast:	n/a	n/a
17	CTCF	chr5:17468420-17468570	A549	lung:	n/a	n/a
18	CTCF	chr5:17491694-17491823	MCF-7	breast:	n/a	n/a
19	CTCF	chr5:17481860-17482010	Caco-2	colon:	n/a	n/a
20	CTCF	chr5:17495120-17495270	Caco-2	colon:	n/a	n/a
21	CTCF	chr5:17468469-17468528	MCF-7	breast:	n/a	n/a
22	CTCF	chr5:17468315-17468678	GM12878	blood:	n/a	n/a
23	CTCF	chr5:17468454-17468538	Spleen_OC	spleen:	n/a	n/a
24	CTCF	chr5:17468481-17468544	GM10248	blood:	n/a	n/a
25	CTCF	chr5:17468443-17468530	GM19238	blood:	n/a	n/a
26	CTCF	chr5:17468429-17468583	MCF-7	breast:	n/a	n/a
27	CTCF	chr5:17468420-17468570	HCPEpiC	choroid plexus:	n/a	n/a
28	CTCF	chr5:17481946-17481996	Hela-S3	cervix:	n/a	n/a
29	CTCF	chr5:17468453-17468523	GM10266	blood:	n/a	n/a
30	CTCF	chr5:17468260-17468410	MCF-7	breast:	n/a	n/a
31	CTCF	chr5:17500777-17500832	GM13976	blood:	n/a	n/a
32	CTCF	chr5:17468421-17468553	K562	blood:	n/a	n/a
33	CTCF	chr5:17463006-17463037	Lung_OC	lung:	n/a	n/a
34	CTCF	chr5:17511524-17511588	LNCaP	prostate:	n/a	n/a
35	CTCF	chr5:17468380-17468610	GM12865	blood:	n/a	n/a
36	CTCF	chr5:17468445-17468539	GM19240	blood:	n/a	n/a
37	CTCF	chr5:17481780-17481930	A549	lung:	n/a	n/a
38	CTCF	chr5:17486619-17486669	Fibrobl	skin:	n/a	n/a
39	CTCF	chr5:17468447-17468543	GM12878	blood:	n/a	n/a
40	CTCF	chr5:17468400-17468550	Caco-2	colon:	n/a	n/a
41	CTCF	chr5:17481840-17481990	BE2_C	brain:	n/a	n/a
42	CTCF	chr5:17468461-17468498	H1-hESC	embryonic stem cell:	n/a	n/a
43	CTCF	chr5:17475913-17475990	LNCaP	prostate:	n/a	n/a
44	CTCF	chr5:17508150-17508159	LNCaP	prostate:	n/a	n/a
45	CTCF	chr5:17481700-17481850	A549	lung:	n/a	n/a
46	CTCF	chr5:17481900-17482050	BE2_C	brain:	n/a	n/a
47	CTCF	chr5:17473433-17473489	GM13976	blood:	n/a	n/a
48	CTCF	chr5:17499727-17499747	LNCaP	prostate:	n/a	n/a
49	CTCF	chr5:17481862-17482016	Gliobla	brain:	n/a	n/a
50	CTCF	chr5:17464299-17464386	Fibrobl	skin:	n/a	n/a

(count:492 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:17485435-17485485	AG04450	lung:	fetal
2	chr5:17485435-17485485	A549	lung:	n/a
3	chr5:17495781-17495831	GM12891	blood:	n/a
4	chr5:17495781-17495831	K562	blood:	n/a
5	chr5:17485435-17485485	AG04450	lung:	fetal
6	chr5:17485435-17485485	A549	lung:	n/a
7	chr5:17495781-17495831	GM12891	blood:	n/a
8	chr5:17495781-17495831	K562	blood:	n/a
9	chr5:17491586-17491636	HPAEpiC	pulmonary alveolar:	n/a
10	chr5:17488879-17488929	NHBE	bronchial:	n/a
11	chr5:17485435-17485485	HMEC	breast:	n/a
12	chr5:17491469-17491519	AG04449	skin:	fetal
13	chr5:17491941-17491991	ovcar-3	ovarian:	n/a
14	chr5:17491941-17491991	Jurkat	blood:	n/a
15	chr5:17491469-17491519	H1-hESC	embryonic stem cell:	embryo
16	chr5:17488879-17488929	NB4	blood:	n/a
17	chr5:17490778-17490828	HEK293	kidney:	embryo
18	chr5:17490778-17490828	RPTEC	kidney:	n/a
19	chr5:17491941-17491991	IMR90	lung:	fetal
20	chr5:17491604-17491654	BE2_C	brain:	n/a
21	chr5:17485435-17485485	HepG2	liver:	n/a
22	chr5:17488879-17488929	HPAEpiC	pulmonary alveolar:	n/a
23	chr5:17491941-17491991	HEK293	kidney:	embryo
24	chr5:17491941-17491991	A549	lung:	n/a
25	chr5:17491604-17491654	ovcar-3	ovarian:	n/a
26	chr5:17491469-17491519	HCF	heart:	n/a
27	chr5:17491604-17491654	U87	brain:	n/a
28	chr5:17490778-17490828	Hepatocyte	liver:	n/a
29	chr5:17488879-17488929	SK-N-SH	brain:	n/a
30	chr5:17490778-17490828	HEEpiC	esophagus:	n/a
31	chr5:17495781-17495831	MCF-7	breast:	n/a
32	chr5:17490778-17490828	Hela-S3	cervix:	n/a
33	chr5:17491604-17491654	HAEpiC	amniotic membrane:	n/a
34	chr5:17491469-17491519	MCF10A-Er-Src	breast:	n/a
35	chr5:17490778-17490828	HepG2	liver:	n/a
36	chr5:17491586-17491636	HNPCEpiC	eye:	n/a
37	chr5:17491941-17491991	AG09309	skin:	n/a
38	chr5:17495781-17495831	HCF	heart:	n/a
39	chr5:17490778-17490828	HCM	heart:	n/a
40	chr5:17491604-17491654	HUVEC	blood vessel:	n/a
41	chr5:17491469-17491519	HCM	heart:	n/a
42	chr5:17495781-17495831	AoSMC	blood vessel:	n/a
43	chr5:17495781-17495831	HEK293	kidney:	embryo
44	chr5:17491469-17491519	GM19239	blood:	n/a
45	chr5:17488879-17488929	GM12892	blood:	n/a
46	chr5:17490778-17490828	NB4	blood:	n/a
47	chr5:17485435-17485485	HL-60	blood:	n/a
48	chr5:17485435-17485485	HRE	kidney:	n/a
49	chr5:17485435-17485485	BE2_C	brain:	n/a
50	chr5:17488879-17488929	HMEC	breast:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:17463203..17464706-chr5:17470171..17472480,2	MCF-7	breast:
2	chr5:17463203..17464706-chr5:17470171..17472480,2	MCF-7	breast:
3	chr5:17223492..17225946-chr5:17474747..17476783,2	MCF-7	breast:
4	chr5:17448288..17450803-chr5:17469886..17472287,2	K562	blood:
5	chr5:17491440..17494172-chr5:17495062..17497549,2	MCF-7	breast:
6	chr5:17491440..17494172-chr5:17495062..17497549,2	MCF-7	breast:
7	chr5:17482145..17483996-chr5:17485919..17488626,2	MCF-7	breast:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BASP1-11	chr5:17494578-17494846	l_2885_chr5:17456969-17494846_brain
2	lnc-BASP1-4	chr5:17483841-17484055	XLOC_004309
3	lnc-BASP1-11	chr5:17465001-17465207	l_2885_chr5:17456969-17494846_brain
4	lnc-BASP1-4	chr5:17483931-17484068	XLOC_004309
5	lnc-BASP1-4	chr5:17485639-17485937	XLOC_004309
6	lnc-BASP1-4	chr5:17477724-17477865	XLOC_004309

No data

Variant related genes	Relation type
ENSG00000251304	TF binding region
ENSG00000268799	TF binding region
ENSG00000249620	TF binding region
ENSG00000248861	TF binding region
ENSG00000248205	TF binding region
ENSG00000250667	TF binding region
ENSG00000185041	TF binding region
ENSG00000251304	CpG island
ENSG00000268799	CpG island
ENSG00000249620	CpG island
ENSG00000248861	CpG island
ENSG00000248205	CpG island
ENSG00000250667	CpG island
ENSG00000185041	CpG island
ENSG00000250667	chromatin interactions
ENSG00000251304	chromatin interactions
ENSG00000268799	chromatin interactions

Extended variants
information (count: 1413 )
Associated
traits (count: 95 )

Variant overlapped rSNPs/rCNVs (count:1413 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs568044711	chr5:17462343-17462344	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs539568441	chr5:17462418-17462419	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs188354931	chr5:17462449-17462450	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs193290613	chr5:17462454-17462455	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs557557530	chr5:17462497-17462498	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs541319195	chr5:17462533-17462534	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs529667158	chr5:17462558-17462559	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs570776437	chr5:17462665-17462666	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs539872162	chr5:17462729-17462730	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs556388990	chr5:17462750-17462751	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs576569134	chr5:17462751-17462752	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs376624202	chr5:17462759-17462760	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs185601995	chr5:17462768-17462769	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs62348780	chr5:17462784-17462785	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs189291099	chr5:17462785-17462786	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs541770090	chr5:17462801-17462802	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs533546308	chr5:17462802-17462803	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs578034578	chr5:17462809-17462810	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs576773305	chr5:17462905-17462906	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs554913478	chr5:17462926-17462927	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs191521770	chr5:17462931-17462932	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs183670573	chr5:17462974-17462975	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs530316289	chr5:17462990-17462991	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs59823663	chr5:17463005-17463006	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs527552631	chr5:17463055-17463056	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs188816581	chr5:17463075-17463076	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs570781450	chr5:17463083-17463084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs117818450	chr5:17463241-17463242	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs367854910	chr5:17463279-17463280	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs550244491	chr5:17463305-17463306	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs570079249	chr5:17463313-17463314	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs144977949	chr5:17463320-17463321	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs367662538	chr5:17463345-17463346	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs370758894	chr5:17463355-17463356	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs555961318	chr5:17463436-17463437	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs572682620	chr5:17463440-17463441	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs181203127	chr5:17463442-17463443	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs115064332	chr5:17463451-17463452	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs187161197	chr5:17463476-17463477	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs545512399	chr5:17463495-17463496	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs562590537	chr5:17463496-17463497	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs189951045	chr5:17463512-17463513	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs542141168	chr5:17463521-17463522	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs181612545	chr5:17463522-17463523	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs548514079	chr5:17463524-17463525	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs112716784	chr5:17463558-17463559	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs527490432	chr5:17463581-17463582	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs541306329	chr5:17463609-17463610	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs530596314	chr5:17463635-17463636	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs375700638	chr5:17463670-17463671	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:95)

Disease	PMID	Source
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Multiple myeloma	17550852	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Esophageal adenocarcinoma	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	21364760	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Myoepithelioma	18604193	CNVD
Lung cancer	16740712	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Melanoma	22183965	CNVD
Renal cell carcinoma	18194544	CNVD
Prostate cancer	21965145	CNVD
Ovarian cancer	20844748	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Autism	19287141	CNVD

Chromatin state (count:52 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:17430800-17463800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr5:17462200-17464400	Enhancers	Primary neutrophils fromperipheralblood	blood
3	chr5:17463800-17464200	Enhancers	HUES48 Cell Line	embryonic stem cell
4	chr5:17463800-17464400	Enhancers	H1 Cell Line	embryonic stem cell
5	chr5:17463800-17464400	Enhancers	HUES64 Cell Line	embryonic stem cell
6	chr5:17463800-17464400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr5:17463800-17464400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr5:17464000-17464400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
9	chr5:17464000-17464400	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr5:17464000-17464400	Enhancers	iPS-15b Cell Line	embryonic stem cell
11	chr5:17465800-17466600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr5:17469400-17470000	Enhancers	Rectal Mucosa Donor 31	rectum
13	chr5:17475000-17475800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr5:17475800-17476200	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr5:17475800-17476400	Enhancers	Primary neutrophils fromperipheralblood	blood
16	chr5:17475800-17476400	Enhancers	Primary B cells from peripheral blood	blood
17	chr5:17476200-17478800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr5:17476400-17486200	Weak transcription	Primary neutrophils fromperipheralblood	blood
19	chr5:17480600-17480800	Enhancers	Fetal Kidney	kidney
20	chr5:17481400-17481600	Enhancers	Fetal Kidney	kidney
21	chr5:17481400-17482000	Enhancers	H1 Cell Line	embryonic stem cell
22	chr5:17481400-17482000	Enhancers	HUES48 Cell Line	embryonic stem cell
23	chr5:17481400-17482000	Enhancers	HUES6 Cell Line	embryonic stem cell
24	chr5:17481400-17482000	Enhancers	HUES64 Cell Line	embryonic stem cell
25	chr5:17481400-17482000	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr5:17481400-17482200	Enhancers	ES-I3 Cell Line	embryonic stem cell
27	chr5:17481400-17483000	Enhancers	A549	lung
28	chr5:17481600-17481800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr5:17481600-17482000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr5:17481600-17482000	Enhancers	iPS-20b Cell Line	embryonic stem cell
31	chr5:17481600-17482000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr5:17483000-17487000	Weak transcription	A549	lung
33	chr5:17486200-17487800	Enhancers	Primary neutrophils fromperipheralblood	blood
34	chr5:17487000-17487600	Enhancers	A549	lung
35	chr5:17487200-17487400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr5:17487200-17487600	Enhancers	Hela-S3	cervix
37	chr5:17487400-17488200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr5:17488200-17489000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr5:17494400-17496200	Enhancers	Primary neutrophils fromperipheralblood	blood
40	chr5:17500600-17500800	Enhancers	A549	lung
41	chr5:17500600-17500800	Enhancers	Hela-S3	cervix
42	chr5:17500600-17501000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
43	chr5:17500600-17501000	Active TSS	NHDF-Ad	bronchial
44	chr5:17502200-17503000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr5:17509000-17509400	Enhancers	Fetal Brain Male	brain
46	chr5:17512000-17512200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr5:17512200-17512400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
48	chr5:17512200-17512400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr5:17512400-17512600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr5:17512600-17517600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links